Shoupe Donna
Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Contracept Reprod Med. 2023 Oct 9;8(1):48. doi: 10.1186/s40834-023-00249-5.
The interlink between bleeding control and contraceptive development has always been an important factor. But after many years of advances in contraceptive technology, this interplay has resulted in development of safer and better contraceptive methods that often offer significantly less bleeding for women with both normal bleeding patterns as well as in those suffering from heavy menstrual bleeding (HMB). Recognition of the success of progestin-only methods, such as the hormonal IUDs, progestin dominant oral contraceptives, and the high dose progestin-only pill in substantially decreasing and controlling menstrual bleeding has led the way. This recognition also led to the development of many [non-contraceptive] protocols to stop acute heavy bleeding as well as manage long-term bleeding [using contraceptive methods as well; as non-contraceptive methods].But even better, there is a new PLUS. The distinct benefit and risk profiles of the many different progestins now available are intentionally being used either in combination contraceptive pills [COCPs] or alone, to add additional benefits, to decrease side effects and risks, and increase effectiveness and bleeding control.
出血控制与避孕技术发展之间的相互联系一直是一个重要因素。但经过多年避孕技术的进步,这种相互作用催生了更安全、更好的避孕方法,这些方法通常能使月经周期正常的女性以及月经过多(HMB)的女性出血量显著减少。对仅含孕激素方法(如激素宫内节育器、以孕激素为主的口服避孕药和仅含高剂量孕激素的药丸)在大幅减少和控制月经出血方面取得成功的认识起到了引领作用。这种认识还促使人们制定了许多[非避孕]方案来停止急性大出血以及[同时使用避孕方法和非避孕方法]处理长期出血问题。但更值得一提的是,现在有了新进展。目前可用的多种不同孕激素独特的益处和风险概况正被有意地用于复方口服避孕药(COCP)中或单独使用,以增加额外益处、减少副作用和风险,并提高有效性和出血控制效果。